Sewoon Medical Co. Ltd (100700) — Cash Flow Quality Index

Latest as of March 2026: 0.87x

Sewoon Medical Co. Ltd (100700) has a Cash Flow Quality Index of 0.87x as of March 2026. Operating cash flow of ₩2.99 Billion is below net income of ₩3.43 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Sewoon Medical Co. Ltd to assess how effectively this company generates cash.

Cash Flow Quality Index

0.87x
Operating CF / Net Income

Operating Cash Flow

₩2.99 Billion
KRW

Net Income

₩3.43 Billion
KRW

Data as of

Mar 2026
Most recent filing

Sewoon Medical Co. Ltd Cash Flow Quality Index (2011–2025)

Historical Cash Flow Quality Index for Sewoon Medical Co. Ltd across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 100700 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Sewoon Medical Co. Ltd (2011–2025)

Year-by-year earnings quality comparison for Sewoon Medical Co. Ltd. For live market cap and the full company financial profile, see Sewoon Medical Co. Ltd market capitalisation.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2025 1.49x ₩17.77 Billion ₩11.91 Billion ▲ +76.8%
2024 0.84x ₩13.19 Billion ₩15.62 Billion ▼ -29.4%
2023 1.20x ₩23.08 Billion ₩19.30 Billion ▲ +34.1%
2022 0.89x ₩9.28 Billion ₩10.41 Billion ▼ -49.0%
2021 1.75x ₩21.47 Billion ₩12.28 Billion ▼ -4.7%
2020 1.83x ₩19.25 Billion ₩10.50 Billion ▲ +28.9%
2019 1.42x ₩13.48 Billion ₩9.48 Billion ▲ +12.8%
2018 1.26x ₩12.19 Billion ₩9.67 Billion ▲ +40.6%
2017 0.90x ₩8.23 Billion ₩9.18 Billion ▲ +54.4%
2016 0.58x ₩6.35 Billion ₩10.93 Billion ▼ -33.6%
2015 0.87x ₩3.65 Billion ₩4.18 Billion ▼ -37.6%
2014 1.40x ₩8.40 Billion ₩5.99 Billion ▲ +24.2%
2013 1.13x ₩9.62 Billion ₩8.52 Billion ▼ -17.2%
2012 1.36x ₩7.19 Billion ₩5.27 Billion ▼ -2.8%
2011 1.40x ₩5.16 Billion ₩3.68 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.